News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
COLUMN GROUP III GP, LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2023 |
4
| COLUMN GROUP III GP, LP (10% Owner) has filed a Form 4 on Tenaya Therapeutics, Inc.|
Txns:
| Bought 69,739 shares
@ $2.4979, valued at
$174.2k
|
|
| 01/19/2023 |
4
| COLUMN GROUP III GP, LP (10% Owner) has filed a Form 4 on Tenaya Therapeutics, Inc.|
Txns:
| Bought 49,463 shares
@ $2.4947, valued at
$123.4k
Bought 135,688 shares
@ $2.5163, valued at
$341.4k
|
|
| 11/23/2022 |
4
| COLUMN GROUP III GP, LP (10% Owner) has filed a Form 4 on Tenaya Therapeutics, Inc.|
Txns:
| Bought 9,615,384 shares
@ $2.6, valued at
$25M
|
|
| 08/23/2021 |
SC 13D
| COLUMN GROUP III GP, LP reports a 25.7% stake in SURROZEN, INC. |
| 08/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/19/2021 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $36.9503, valued at
$369.5k
|
|
| 12/16/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Exercised (in-or-at-the-money) 30,107 warrants
@ $1.55, valued at
$46.7k
|
|
| 11/18/2020 |
4
| COLUMN GROUP III, LP (10% Owner) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Sold 952,023 shares
@ $36.4, valued at
$34.7M
Sold 1,075,133 shares
@ $36.4, valued at
$39.1M
|
|
| 09/03/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 36,494 shares
@ $17.64, valued at
$643.8k
Bought 27,595 shares
@ $17.67, valued at
$487.6k
|
|
| 08/31/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 36,359 shares
@ $17.79, valued at
$646.8k
Bought 26,135 shares
@ $17.89, valued at
$467.6k
|
|
| 08/25/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 7,321 shares
@ $17.97, valued at
$131.6k
Bought 11,024 shares
@ $17.96, valued at
$198k
Bought 100 shares
@ $18, valued at
$1.8k
|
|
| 08/17/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 19,895 shares
@ $17.89, valued at
$355.9k
Bought 37,993 shares
@ $17.49, valued at
$664.5k
Bought 6,425 shares
@ $17.89, valued at
$114.9k
|
|
| 08/03/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 732 shares
@ $17.99, valued at
$13.2k
|
|
| 07/30/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 4,105 shares
@ $17.99, valued at
$73.8k
|
|
| 07/28/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 68,749 shares
@ $17.93, valued at
$1.2M
Bought 3,834 shares
@ $17.99, valued at
$69k
|
|
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| COLUMN GROUP III, LP (10% Owner) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Acquired 7,234 shares
@ $0
Acquired 25,318 options to buy
@ $36.57, valued at
$925.9k
Acquired 36,168 options to buy
@ $17, valued at
$614.9k
|
|
| 04/09/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 112,602 shares
@ $14.95, valued at
$1.7M
|
|
| 04/07/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 14,587 shares
@ $12.41, valued at
$181k
Bought 123,728 shares
@ $14.38, valued at
$1.8M
|
|
| 04/02/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 118,067 shares
@ $12.53, valued at
$1.5M
Bought 118,067 shares
@ $12.26, valued at
$1.4M
Bought 14,850 shares
@ $12.4, valued at
$184.1k
|
|
| 03/25/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 170,387 shares
@ $11.63, valued at
$2M
Bought 128,377 shares
@ $12.22, valued at
$1.6M
Bought 2,416 shares
@ $12.49, valued at
$30.2k
|
|
| 03/23/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Bought 36,135 shares
@ $22.38, valued at
$808.7k
Bought 5,539 shares
@ $23.15, valued at
$128.2k
|
|
| 03/23/2020 |
3
| COLUMN GROUP III, LP (10% Owner) has filed a Form 3 on CONSTELLATION PHARMACEUTICALS INC |
| 03/23/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 148,464 shares
@ $11.59, valued at
$1.7M
Bought 143,082 shares
@ $11.77, valued at
$1.7M
|
|
| 03/06/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 8,307 shares
@ $18, valued at
$149.5k
|
|
| 03/04/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 14,124 shares
@ $17.9, valued at
$252.8k
Bought 38,758 shares
@ $17.99, valued at
$697.3k
Bought 9,986 shares
@ $17.96, valued at
$179.3k
|
|
| 02/28/2020 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 33,896 shares
@ $17.91, valued at
$607.1k
Bought 37,800 shares
@ $17.91, valued at
$677k
Bought 3,751 shares
@ $18, valued at
$67.5k
|
|
| 02/19/2020 |
3/A
| COLUMN GROUP III, LP (10% Owner) has filed a Form 3/A on NGM BIOPHARMACEUTICALS INC |
| 02/18/2020 |
4
| COLUMN GROUP III, LP (10% Owner) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Converted 7,977,384 shares
@ $0
Converted 5,137,583 preferred shares
@ $0
Converted 2,740,043 preferred shares
@ $0
Converted 99,758 preferred shares
@ $0 |
|
| 02/12/2020 |
3
| COLUMN GROUP III, LP (10% Owner) has filed a Form 3 on Revolution Medicines, Inc. |
|
|
|